106 related articles for article (PubMed ID: 8547132)
21. Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles.
Yamazaki K; Yamada E; Kanaji Y; Shizume K; Wang DS; Maruo N; Obara T; Sato K
Endocrinology; 1996 Nov; 137(11):4857-63. PubMed ID: 8895357
[TBL] [Abstract][Full Text] [Related]
22. A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.
Oh JW; Revel M; Chebath J
Cytokine; 1996 May; 8(5):401-9. PubMed ID: 8726669
[TBL] [Abstract][Full Text] [Related]
23. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma.
Kyrtsonis MC; Dedoussis G; Zervas C; Perifanis V; Baxevanis C; Stamatelou M; Maniatis A
Br J Haematol; 1996 May; 93(2):398-400. PubMed ID: 8639436
[TBL] [Abstract][Full Text] [Related]
24. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
Lavabre-Bertrand T; Duperray C; Brunet C; Poncelet P; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Brochier J; Navarro M; Janossy G
Leukemia; 1994 Mar; 8(3):402-8. PubMed ID: 8127145
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
26. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor.
Thibault V; Terlain B; Gauldie J
J Interferon Cytokine Res; 1996 Nov; 16(11):973-81. PubMed ID: 8938575
[TBL] [Abstract][Full Text] [Related]
27. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
28. Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells.
Campard D; Vasse M; Rose-John S; Poyer F; Lamacz M; Vannier JP
Stem Cells; 2006 May; 24(5):1302-14. PubMed ID: 16357344
[TBL] [Abstract][Full Text] [Related]
29. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
30. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
[TBL] [Abstract][Full Text] [Related]
31. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
32. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
Geisterfer M; Richards CD; Gauldie J
Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
[TBL] [Abstract][Full Text] [Related]
33. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
34. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
[TBL] [Abstract][Full Text] [Related]
35. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
36. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
Scudla V; Kubalová D; Bacovský J; Lukes J; Vavrdová V
Cas Lek Cesk; 1996 Nov; 135(22):719-22. PubMed ID: 8998823
[TBL] [Abstract][Full Text] [Related]
37. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
[TBL] [Abstract][Full Text] [Related]
38. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
39. Alternative assay procedures for cytokines and soluble receptors of the IL-6 family.
Oppmann B; Stoyan T; Fischer M; Voltz N; März P; Rose-John S
J Immunol Methods; 1996 Sep; 195(1-2):153-9. PubMed ID: 8814331
[TBL] [Abstract][Full Text] [Related]
40. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
